Overview

TEAM: Testosterone Supplementation and Exercise in Elderly Men

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
0
Participant gender:
Male
Summary
The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Institute on Aging (NIA)
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
Criteria
Inclusion Criteria:

- Generally healthy, untrained men 60 years or older with low-normal testosterone levels
(200-350ng/dL)

- Must reside in the Denver metro area

Exclusion Criteria:

- Prostate/breast cancer

- Unable to exercise safely

- severe obesity (>34 body mass index [BMI])

- Polycythemia

- Diabetes

- Use of drugs that could affect T levels

- Cognitive dysfunction (MMSE less than 24)

- PSA above the age-adjusted normal level or AUA greater than 19

- Unable to pass stress test due to active CAD